SXTC Stock Analysis: Buy, Sell, or Hold?
SXTC - China SXT Pharmaceuticals, Inc. Ordinary Shares
$1.60
0.01 (0.63%)
▲
5d:
-3.61%
30d:
-13.98%
90d:
-39.16%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Get Alerted When SXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SXTC this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SXTC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: SXTC shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: SXTC is currently trading at $1.60, which is considered oversold relative to its 30-day fair value range of $1.76 to $2.17.
Technical Outlook: Technically, SXTC is in a uptrend. Immediate support is located at $1.50, while resistance sits at $2.10.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SXTC is in a uptrend. Immediate support is located at $1.50, while resistance sits at $2.10.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.76 -
$2.17
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
Trading Range Analysis
30-Day Trading Range
$1.76 -
$2.17
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$2.10
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Revenue Growth (YoY)
-24.5%
Earnings Growth (YoY)
42.6%
Share & Embed Analysis
Last updated: May 14, 2026 6:49 PM ET
Data refreshes hourly during market hours. Next update: 7:49 PM
Data refreshes hourly during market hours. Next update: 7:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$136 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$102 | 59 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 56 HOLD |
